Table 2.
Analysis of IL-6, IL-8, and TNF-α levels after treatment.
| Outcomes | Number of included studies | Heterogeneity | Effect model | SMD (95%CI) | P | |
|---|---|---|---|---|---|---|
| P | I 2 (%) | |||||
| IL-6 | 3 | 0.49 | 0 | Fixed-effects model | −1.61 [−1.91, −1.30] | <0.00001 |
| IL-8 | 3 | 0.31 | 13 | Fixed-effects model | −1.68 [−1.99, −1.38] | <0.00001 |
| TNF-α | 3 | 0.59 | 0 | Fixed-effects model | −1.68 [−1.98, −1.37] | <0.00001 |